MOLECULE HOLDINGS Net Assets
MOLECULE HOLDINGS net assets. Based on the latest financial reports, MOLECULE HOLDINGS (ERV2) has net assets worth €- EUR (≈ $- USD) as of . Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€- ≈ $- USD) and total liabilities (€- ≈ $- USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore net asset growth rate of MOLECULE HOLDINGS to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Net Assets of MOLECULE HOLDINGS (2021–2022)
Net assets of MOLECULE HOLDINGS from 2021 to 2022. This chart illustrates how MOLECULE HOLDINGS's net assets have evolved over time, based on quarterly financial data. See ERV2 equity financing ratio to measure how much of total assets are equity-financed.
Annual Net Assets for MOLECULE HOLDINGS (2021–2022)
The table below shows the annual net assets of MOLECULE HOLDINGS from 2021 to 2022. For live market cap and overall valuation, see market cap of MOLECULE HOLDINGS.
| Year | Net Assets | Change |
|---|---|---|
| 2022-10-31 | €-3.69 Million ≈ $-4.32 Million |
-678.77% |
| 2021-10-31 | €638.39K ≈ $746.34K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to MOLECULE HOLDINGS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 454392100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
MOLECULE HOLDINGS Net Assets Breakdown (October 2022)
MOLECULE HOLDINGS net assets breakdown by equity component as of October 2022.
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €9.49 Million | % |
| Total Equity | €-3.69 Million | 100.00% |
MOLECULE HOLDINGS Competitors by Market Cap
The table below lists competitors of MOLECULE HOLDINGS ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Bisichi Mining PLC
LSE:BISI
|
$57.16K |
|
Harmony Energy Income Trust PLC
LSE:HEIT
|
$57.20K |
|
Philipp Holzmann AG
DU:HOZ
|
$57.22K |
|
Trafalgar New Homes Plc
LSE:TRAF
|
$57.39K |
|
Bumrungrad Hospital Public Company Limited
F:BZ7A
|
$56.99K |
|
ENVIROMETAL TECHN. O.N.
F:7N20
|
$56.80K |
|
Trakm8 Holdings PLC
LSE:TRAK
|
$56.24K |
|
Cizzle Biotechnology Holdings PLC
LSE:CIZ
|
$55.46K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MOLECULE HOLDINGS's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from 638,388 to -3,694,772, a change of -4,333,160 (-678.8%).
- Net loss of 4,543,921 reduced equity.
- Other factors increased equity by 210,761.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-4.54 Million | -122.98% |
| Other Changes | €210.76K | +5.7% |
| Total Change | €- | -678.77% |
Book Value vs Market Value Analysis
This analysis compares MOLECULE HOLDINGS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-10-31 | €0.01 | €0.00 | x |
| 2022-10-31 | €-0.04 | €0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently MOLECULE HOLDINGS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -230.84%
- • Asset Turnover: 0.50x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-331.10%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -662.19% | -928.56% | 0.08x | 9.33x | €-4.29 Million |
| 2022 | 0.00% | -230.84% | 0.50x | 0.00x | €-4.17 Million |
Industry Comparison
This section compares MOLECULE HOLDINGS's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $9,676,957,497
- Average return on equity (ROE) among peers: -45.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| MOLECULE HOLDINGS (ERV2) | €- | -662.19% | N/A | $57.16K |
| SHANG.FOS.PHARM.GR.H YC 1 (08HH) | $61.84 Billion | 5.45% | 0.94x | $1.20 Billion |
| PEPTONIC MEDICAL (28L) | $75.32 Million | -56.54% | 0.42x | $5.52 Million |
| Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) | $5.95 Billion | 11.12% | 0.39x | $692.11 Million |
| WEST ISLAND BRANDS INC. (39N0) | $3.27 Million | -157.21% | 0.88x | $1.34 Million |
| HANSOH PHARMAC. HD-00001 (3KY) | $28.68 Billion | 15.24% | 0.10x | $22.06 Billion |
| AYURCANN HOLDINGS CORP. (3ZQ0) | $2.69 Million | -197.11% | 3.73x | $97.35K |
| CERENO SCIENTIFIC AB B (4A1) | $216.42 Million | -22.23% | 0.32x | $57.92 Million |
| MAPLE LEAF GREEN WORLD (4HV0) | $-8.51 Million | 0.00% | 0.00x | $504.30K |
| LORDS CO. WORLDW. HOLD. (4XM) | $-1.01 Million | 0.00% | 0.00x | $134.78K |
| RED LIGHT HOLLAND CORP. (4YX) | $11.22 Million | -54.38% | 0.30x | $6.62 Million |
About MOLECULE HOLDINGS
Molecule Holdings Inc. engages in production and co-packing of cannabis-infused beverages in Canada. It also offers cannabis extracts, beverages, edibles, and topical products directly to provincial retailers. The company offers its beverage products under the PHRESH, KLÕN, EMBODY, and CANAJO brands. Molecule Holdings Inc. is based in Lansdowne, Canada.